BSX vs LSTA · P/E 20, rev $10.65B vs $31.7M cap
Boston Scientific Corp (BSX) versus Lisata Therapeutics Inc. (LSTA) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Lisata Therapeutics Inc. (LSTA) is a biotechnology company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported LSTA revenue for 2026-06-30 was $0. Net income was -$7.4M. LSTA currently screens at market cap $31.7M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. LSTA currently screens at market cap $31.7M.
Not investment advice. Open the BSX and LSTA stock pages for the full models.
Not investment advice.